Skip to menu Skip to content Skip to footer

2016

Journal Article

A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy

Tan, Hendrick, Joseph, David, Loh, Nelson K., McCarthy, Michael, Leong, Eugene, Siew, Teck, Segard, Tatiana, Morandeau, Laurence, Trevenen, Michelle and Francis, Roslyn J. (2016). A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy. Journal of Medical Imaging and Radiation Oncology, 60 (3), 374-381. doi: 10.1111/1754-9485.12455

A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy

2015

Journal Article

A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma

Nowak, A. K., Cook, A. M., McDonnell, A. M., Millward, M. J., Creaney, J., Francis, R. J., Hasani, A., Segal, A., Musk, A. W., Turlach, B. A., McCoy, M. J., Robinson, B. W.S. and Lake, R. A. (2015). A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma. Annals of Oncology, 26 (12), 2483-2490. doi: 10.1093/annonc/mdv387

A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma

2015

Journal Article

Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT

Francis, Roslyn J., Segard, Tatiana, Morandeau, Laurence, Lee, Y.C. Gary, Millward, Michael J., Segal, Amanda and Nowak, Anna K. (2015). Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT. Lung Cancer, 90 (1), 55-60. doi: 10.1016/j.lungcan.2015.07.015

Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT

2015

Journal Article

A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study

Willowson, Kathy P., Tapner, Michael, The QUEST Investigator Team, , Bailey, Dale L., Willowson, K. P., Tapner, M. J., Ahmadzadehfar, H., Amthauer, H., Großer, O. S., Arbizu, J., Martí-Climent, J. M., Rodriguez-Fraile, M., Attarwala, A. A., Glatting, G., Molina-Duran, F., Bagni, O., Filippi, L., Benard, F., Celler, A., Bonutti, F., Botta, F., Ferrari, M., Boucek, J. A., Francis, R., Bourgeois, A. C., Bradley, Y. C., Pasciak, A. S., Buchholz, H. G., Miederer, M. ... Yu, N. (2015). A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study. European Journal of Nuclear Medicine and Molecular Imaging, 42 (8), 1202-1222. doi: 10.1007/s00259-015-3059-9

A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study

2014

Journal Article

Interventional therapies for malignant pleural effusions: The present and the future

Thomas, Rajesh, Francis, Roslyn, Davies, Helen E. and Gary Lee, Y. C. (2014). Interventional therapies for malignant pleural effusions: The present and the future. Respirology, 19 (6), 809-822. doi: 10.1111/resp.12328

Interventional therapies for malignant pleural effusions: The present and the future

2014

Journal Article

A Gelatin liver phantom of suspended 90Y resin microspheres to simulate the physiologic microsphere biodistribution of a postradioembolization liver

Kao, Yung Hsiang, Luddington, Oliver S., Culleton, Simone R., Francis, Roslyn J. and Boucek, Jan A. (2014). A Gelatin liver phantom of suspended 90Y resin microspheres to simulate the physiologic microsphere biodistribution of a postradioembolization liver. Journal of Nuclear Medicine Technology, 42 (4), 265-268. doi: 10.2967/jnmt.114.145292

A Gelatin liver phantom of suspended 90Y resin microspheres to simulate the physiologic microsphere biodistribution of a postradioembolization liver

2014

Journal Article

Observer variability in mesothelioma tumor thickness measurements: Defining minimally measurable lesions

Armato III, Samuel G., Nowak, Anna K., Francis, Roslyn J., Kocherginsky, Masha and Byrne, Michael J. (2014). Observer variability in mesothelioma tumor thickness measurements: Defining minimally measurable lesions. Journal of Thoracic Oncology, 9 (8), 1187-1194. doi: 10.1097/JTO.0000000000000211

Observer variability in mesothelioma tumor thickness measurements: Defining minimally measurable lesions

2013

Journal Article

Mycobacterium mimicking metastatic melanoma

Teh, R. W., Feeney, K., Francis, R. J., Phillips, M. and Millward, M. J. (2013). Mycobacterium mimicking metastatic melanoma. Internal Medicine Journal, 43 (12), 1342-1346. doi: 10.1111/imj.12209

Mycobacterium mimicking metastatic melanoma

2013

Journal Article

Post-radioembolization yttrium-90 PET/CT-part 2: Dose-response and tumor predictive dosimetry for resin microspheres

Kao, Yung-Hsiang, Steinberg, Jeffrey D., Tay, Young-Soon, Lim, Gabriel K. Y., Yan, Jianhua, Townsend, David W., Budgeon, Charley, Boucek, Jan A., Francis, Roslyn J., Cheo, Timothy S. T., Burgmans, Mark C., Irani, Farah G., Lo, Richard H. G., Tay, Kiang-Hiong, Tan, Bien-Soo, Chow, Pierce K. H., Satchithanantham, Somanesan, Tan, Andrew E. H., Ng, David C. E. and Goh, Anthony S. W. (2013). Post-radioembolization yttrium-90 PET/CT-part 2: Dose-response and tumor predictive dosimetry for resin microspheres. EJNMMI Research, 3 (1), 1-27. doi: 10.1186/2191-219X-3-57

Post-radioembolization yttrium-90 PET/CT-part 2: Dose-response and tumor predictive dosimetry for resin microspheres

2013

Journal Article

Detection of hypoxia with 18F-fluoromisonidazole ( 18F-FMISO) PET/CT in suspected or proven pancreatic cancer

Segard, Tatiana, Robins, Peter D., Yusoff, Ian F., Ee, Hooi, Morandeau, Laurence, Campbell, Elaine M. and Francis, Roslyn J. (2013). Detection of hypoxia with 18F-fluoromisonidazole ( 18F-FMISO) PET/CT in suspected or proven pancreatic cancer. Clinical Nuclear Medicine, 38 (1), 1-6. doi: 10.1097/RLU.0b013e3182708777

Detection of hypoxia with 18F-fluoromisonidazole ( 18F-FMISO) PET/CT in suspected or proven pancreatic cancer

2012

Journal Article

A phase ii study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma

Nowak, Anna K., Millward, Michael J., Creaney, Jenette, Francis, Roslyn J., Dick, Ian M., Hasani, Arman, Van Der Schaaf, Agatha, Segal, Amanda, Musk, Arthur W. and Byrne, Michael J. (2012). A phase ii study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma. Journal of Thoracic Oncology, 7 (9), 1449-1456. doi: 10.1097/JTO.0b013e31825f22ee

A phase ii study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma

2011

Journal Article

A snapshot of research activities at the WA PET service

Francis, Roslyn, Segard, Tatiana, Maton, Penny and Campbell, Elaine (2011). A snapshot of research activities at the WA PET service. Gamma Gazette, 1 (4), 24-25.

A snapshot of research activities at the WA PET service

2011

Journal Article

A multimodality imaging review of malignant pleural mesothelioma response assessment

Nowak, Anna K., Francis, Roslyn J., Katz, Sharyn I. and Gerbaudo, Victor H. (2011). A multimodality imaging review of malignant pleural mesothelioma response assessment. PET Clinics, 6 (3), 299-311. doi: 10.1016/j.cpet.2011.04.002

A multimodality imaging review of malignant pleural mesothelioma response assessment

2011

Journal Article

Multimodality imaging review of malignant pleural mesothelioma diagnosis and staging

Gerbaudo, Victor H., Katz, Sharyn I., Nowak, Anna K. and Francis, Roslyn J. (2011). Multimodality imaging review of malignant pleural mesothelioma diagnosis and staging. PET Clinics, 6 (3), 275-297. doi: 10.1016/j.cpet.2011.04.001

Multimodality imaging review of malignant pleural mesothelioma diagnosis and staging

2011

Journal Article

Serum soluble mesothelin concentrations in malignant pleural mesothelioma: Relationship to tumor volume, clinical stage and changes in tumor burden

Creaney, Jenette, Francis, Roslyn J., Dick, Ian M., Musk, Arthur W., Robinson, Bruce W. S., Byrne, Michael J. and Nowak, Anna K. (2011). Serum soluble mesothelin concentrations in malignant pleural mesothelioma: Relationship to tumor volume, clinical stage and changes in tumor burden. Clinical Cancer Research, 17 (5), 1181-1189. doi: 10.1158/1078-0432.CCR-10-1929

Serum soluble mesothelin concentrations in malignant pleural mesothelioma: Relationship to tumor volume, clinical stage and changes in tumor burden

2010

Journal Article

Imaging in pleural mesothelioma: A review of Imaging Research Presented at the 9th International Meeting of the International Mesothelioma Interest Group

Nowak, Anna K., Armato, Samuel G., Ceresoli, Giovanni Luca, Yildirim, Huseyin and Francis, Roslyn J. (2010). Imaging in pleural mesothelioma: A review of Imaging Research Presented at the 9th International Meeting of the International Mesothelioma Interest Group. Lung Cancer, 70 (1), 1-6. doi: 10.1016/j.lungcan.2010.05.016

Imaging in pleural mesothelioma: A review of Imaging Research Presented at the 9th International Meeting of the International Mesothelioma Interest Group

2010

Journal Article

A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters

Nowak, Anna K., Francis, Roslyn J., Phillips, Michael J., Millward, Michael J., Van Der Schaaf, Agatha A., Boucek, Jan, Musk, Arthur W., McCoy, Melanie J., Segal, Amanda, Robins, Peter, Byrne, Michael J. and Jolghazi, Anna (2010). A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters. Clinical Cancer Research, 16 (8), 2409-2417. doi: 10.1158/1078-0432.CCR-09-2313

A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters

2009

Journal Article

A phase I clinical trial of CHT-25 a 131I-labeled chimeric anti-CD25 antibody showing efficacy in patients with refractory lymphoma

Dancey, Gairin, Violet, John, Malaroda, Alessandra, Green, Alan J., Sharma, Surinder K., Francis, Roslyn, Othman, Shokri, Parker, Sweta, Buscombe, John, Griffin, Natalie, Chan, Pei-San, Malhotra, Anmol, Woodward, Nicholas, Ramsay, Alan, Ross, Philip, Lister, T. Andrew, Amlot, Peter, Begent, Richard and McNamara, Christopher (2009). A phase I clinical trial of CHT-25 a 131I-labeled chimeric anti-CD25 antibody showing efficacy in patients with refractory lymphoma. Clinical Cancer Research, 15 (24), 7701-7710. doi: 10.1158/1078-0432.CCR-09-1421

A phase I clinical trial of CHT-25 a 131I-labeled chimeric anti-CD25 antibody showing efficacy in patients with refractory lymphoma

2008

Journal Article

Assessment of tumour response with 18F-fluorodeoxyglucose positron emission tomography using three-dimensional measures compared to SUVmax - A phantom study

Boucek, J. A., Francis, R. J., Jones, C. G., Khan, N., Turlach, B. A. and Green, A. J. (2008). Assessment of tumour response with 18F-fluorodeoxyglucose positron emission tomography using three-dimensional measures compared to SUVmax - A phantom study. Physics in Medicine and Biology, 53 (16), 4213-4230. doi: 10.1088/0031-9155/53/16/001

Assessment of tumour response with 18F-fluorodeoxyglucose positron emission tomography using three-dimensional measures compared to SUVmax - A phantom study

2008

Journal Article

Semiautomatic volume of interest drawing for 18F-FDG image analysis - Method and preliminary results

Green, A. J., Francis, R. J., Baig, S. and Begent, R. H.J. (2008). Semiautomatic volume of interest drawing for 18F-FDG image analysis - Method and preliminary results. European Journal of Nuclear Medicine and Molecular Imaging, 35 (2), 393-406. doi: 10.1007/s00259-007-0602-3

Semiautomatic volume of interest drawing for 18F-FDG image analysis - Method and preliminary results